Found 45 matching trials
Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer PHASE2 This prospective real-world study aims to evaluate the effectiveness and sa...
Show More Location
Air Force Military Medical University
Learn More & Join Trial
RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer PHASE2 This study is a prospective, open-label, phase II clinical trial that aims ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma PHASE2 To evaluate the initial efficacy and safety of paclitaxel for injection (al...
Show More Location
The First Affiliated Hospital of Xiamen University
Learn More & Join Trial
Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy PHASE2 Patients with locally advanced unresectable or metastatic hepatocellular ca...
Show More Location
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Learn More & Join Trial
Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer PHASE2 This is a prospective, single-arm exploratory study to evaluate the efficac...
Show More Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Learn More & Join Trial
Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC. PHASE2 To assess the efficacy and safety of adebrelimab in combination with apatin...
Show More Location
The First Affiliated Hospital of Henan University of Science and Technology
Learn More & Join Trial
Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma PHASE2 This study is designed to combine anti-angiogenic drugs on the basis of PD-...
Show More Learn More & Join Trial
Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer PHASE2 This is a prospective, single-center, single-arm, open phase II clinical st...
Show More Location
Beijing Friendship Hospital, Capital Medical University
Learn More & Join Trial
Adebrelimab + Apatinib in SCLC Maintenance Therapy PHASE2 This prospective clinical study aims to evaluate and observe the efficacy a...
Show More Location
Tangdu Hospital Affiliated to the Fourth Military Medical University
Learn More & Join Trial
A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer PHASE2 To evaluate the efficacy and safety of apatinib combined with adebrelizumab...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial